Financials data is unavailable for this security.
View more
Year on year Cosmo Bio Co Ltd 's net income fell -14.31% from 517.00m to 443.00m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 26.61% to 28.44%.
| Gross margin | 33.17% |
|---|---|
| Net profit margin | 3.64% |
| Operating margin | 4.01% |
| Return on assets | 3.11% |
|---|---|
| Return on equity | 3.83% |
| Return on investment | 3.62% |
More ▼
Cash flow in JPYView more
In 2023, cash reserves at Cosmo Bio Co Ltd fell by 210.00m. However, the company earned 736.00m from its operations for a Cash Flow Margin of 7.88%. In addition the company used 758.00m on investing activities and also paid 201.00m in financing cash flows.
| Cash flow per share | 84.08 |
|---|---|
| Price/Cash flow per share | 13.51 |
| Book value per share | 1,569.72 |
|---|---|
| Tangible book value per share | 1,541.04 |
More ▼
Balance sheet in JPYView more
| Current ratio | 7.36 |
|---|---|
| Quick ratio | 6.28 |
| Total debt/total equity | 0.0022 |
|---|---|
| Total debt/total capital | 0.002 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -16.67% and -14.85%, respectively. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 2.76% |
|---|---|
| Div growth rate (5 year) | 16.47% |
| Payout ratio (TTM) | 51.62% |
| EPS growth(5 years) | 11.57 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -28.28 |
More ▼
